Ignite Creation Date:
2024-05-06 @ 1:40 AM
Last Modification Date:
2024-10-26 @ 11:07 AM
Study NCT ID:
NCT01868022
Status:
COMPLETED
Last Update Posted:
2019-08-19
First Post:
2013-05-30
Brief Title:
Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor FGF Pathway Signaling
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline